Exploring the Link Between Bevacizumab and Gastrointestinal Perforations Using the FDA Adverse Event Reporting System Database

被引：0
|
作者：
Wichelmann, Thomas A. [1 ]
Abdulmujeeb, Sufyan [1 ]
Ehrenpreis, Eli D. [1 ]
机构：
[1] Advocate Lutheran Gen Hosp, Park Ridge, IL USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2020年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S0236
引用
收藏
页码：S114 / S115
页数：3
相关论文
共 50 条
  • [31] A Review of Dental Adverse Events Using the FDA Adverse Event Reporting System
    Altman, Keith
    Budny, Renata
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 400 - 400
  • [32] A Review of Adverse Drug Reactions for Bevacizumab-awwb and Bevacizumab-bvzr in the Treatment of Metastatic Colorectal Cancer Reported to the FDA Adverse Event Reporting System Database
    Wichelmann, Thomas A.
    AbdulMujeeb, Sufyan
    Ehrenpreis, Eli D.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S93 - S93
  • [33] Real-world data analysis of topotecan in combination with Bevacizumab or CycloPhosphamide in the FDA adverse event reporting system (FAERS) database
    Chen, Huihui
    Zhuang, Guobiao
    Hong, Shihao
    Wu, Jing
    EXPERT OPINION ON DRUG SAFETY, 2025,
  • [34] DRUG-INDUCED ACUTE RENAL FAILURE USING THE FDA ADVERSE EVENT REPORTING SYSTEM DATABASE
    Alhammad, A. M.
    Al Hawaj, M. A.
    Alsalman, A. J.
    Alhashem, Y. N.
    Harpe, S. E.
    Smith, W. R.
    Brophy, D. F.
    VALUE IN HEALTH, 2011, 14 (03) : A74 - A74
  • [35] Association between GvHD and nivolumab in the FDA adverse event reporting system
    Oshima, Y.
    Tanimoto, T.
    Yuji, K.
    Tojo, A.
    BONE MARROW TRANSPLANTATION, 2017, 52 (10) : 1463 - 1464
  • [36] Association between GvHD and nivolumab in the FDA adverse event reporting system
    Y Oshima
    T Tanimoto
    K Yuji
    A Tojo
    Bone Marrow Transplantation, 2017, 52 : 1463 - 1464
  • [37] Exploring the Rising Incidence of Myocarditis and Other Cardiovascular Adverse Events of Nivolumab and Ipilimumab: Analysis of FDA Adverse Event Reporting System Database
    Khanal, Resha
    Oli, Sharad
    Rajak, Kripa
    Halder, Anupam
    Hufdhi, Raied
    Bhandari, Binita
    Oli, Shital
    Alraies, M. Chadi C.
    CIRCULATION, 2023, 148
  • [38] Exploring the Link Between Exogenous Thyroid Hormones and Dementia Symptoms: A Real-World Disproportionality Analysis of FDA Adverse Event Reporting System
    Zhou, Jianxing
    Lai, Weipeng
    Wei, Zipeng
    Xu, Baohua
    Liu, Maobai
    Zhang, Nanwen
    Wu, Xuemei
    ANNALS OF PHARMACOTHERAPY, 2025, 59 (01) : 23 - 33
  • [39] Pharmacovigilance of esketamine nasal spray: an analysis of the FDA adverse event reporting system database
    Liu, Ruixue
    Liu, Chunxiao
    Feng, Dianwei
    Guo, Tongxin
    Wang, Ying
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [40] The drug risks of cilostazol: A pharmacovigilance study of FDA Adverse Event Reporting System database
    Peng, Lufeng
    Li, Xueli
    Li, Junhai
    Liu, Shibin
    Liang, Gang
    PLOS ONE, 2024, 19 (12):
12345